Matches in Wikidata for { <http://www.wikidata.org/entity/Q99589908> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q99589908 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99589908 description "scientific article published on 18 September 2020" @default.
- Q99589908 description "wetenschappelijk artikel" @default.
- Q99589908 description "наукова стаття, опублікована 18 вересня 2020" @default.
- Q99589908 name "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 name "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 type Item @default.
- Q99589908 label "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 label "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 prefLabel "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 prefLabel "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 P1433 Q99589908-CD6D859D-DED4-44A4-B249-5C5B58D77FF2 @default.
- Q99589908 P1476 Q99589908-9F7EA7F4-2D04-4F68-AC6E-65D097FCE986 @default.
- Q99589908 P2093 Q99589908-0646A644-347B-40D6-BD1C-527C4A27CD0A @default.
- Q99589908 P2093 Q99589908-19872752-D697-4305-92D0-8D78C9C2EC0B @default.
- Q99589908 P2093 Q99589908-79BE1FDA-3F0A-4DFB-9764-7DE5DC05F118 @default.
- Q99589908 P2093 Q99589908-7CE580FE-0738-49C8-88FF-042020B48E3B @default.
- Q99589908 P2093 Q99589908-AD159708-8552-4D29-B104-886EEB311E19 @default.
- Q99589908 P2093 Q99589908-CB412CA9-9B04-4C9A-A111-BC40029DA967 @default.
- Q99589908 P2093 Q99589908-FBADC40E-A9F2-4EDA-AA84-C3DEF5C2B546 @default.
- Q99589908 P304 Q99589908-87874FF6-FBBD-4458-B566-4256AF31CA61 @default.
- Q99589908 P31 Q99589908-2151A873-16A2-49C0-957C-10C8D545CDF2 @default.
- Q99589908 P356 Q99589908-63B267D7-7880-4DC7-B435-7DCCC9827A5D @default.
- Q99589908 P577 Q99589908-18B6E6AA-4A7E-4404-9FA7-E0B88244345B @default.
- Q99589908 P698 Q99589908-73853361-8DDE-4671-A667-B445090ED7EB @default.
- Q99589908 P921 Q99589908-061CD6AE-30A8-4D6E-A2BE-2BD4B3A8578E @default.
- Q99589908 P356 J.TAAP.2020.115246 @default.
- Q99589908 P698 32956689 @default.
- Q99589908 P1433 Q2446974 @default.
- Q99589908 P1476 "Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1/2, p38α, and NF-κB signaling" @default.
- Q99589908 P2093 "Ahmed Shata" @default.
- Q99589908 P2093 "Eman M Abd El-Kader" @default.
- Q99589908 P2093 "Hossam Sharaf" @default.
- Q99589908 P2093 "Noha A Amin" @default.
- Q99589908 P2093 "Rania Khalil" @default.
- Q99589908 P2093 "Sameh Saber" @default.
- Q99589908 P2093 "Walied S Abdo" @default.
- Q99589908 P304 "115246" @default.
- Q99589908 P31 Q13442814 @default.
- Q99589908 P356 "10.1016/J.TAAP.2020.115246" @default.
- Q99589908 P577 "2020-09-18T00:00:00Z" @default.
- Q99589908 P698 "32956689" @default.
- Q99589908 P921 Q411114 @default.